ADxRx is committed to making a difference in patients’ lives through the development of cancer diagnostic tests, companion diagnostic and monitoring tests, and anti-cancer antibody therapies.

ADxRx Initiatives are :

• Collaborate with drug development and diagnostic companies on the development of effective diagnostic tools using unique biomarkers and monoclonal antibodies
• Current internal collaboration initiative with Thermo Fisher Scientific for the diagnosis of metastatic cancer
• Early Diagnosis of pancreatic cancer initiative (biomarker panel)